Literature DB >> 4885252

Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis.

H J Oosterhuis, J Bethlem, T E Feltkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4885252      PMCID： PMC496401          DOI： 10.1136/jnnp.31.5.460

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  14 in total

1.  Studies in myasthenia gravis. 2. The relation of some clinical and immunological data.

Authors:  H J Oosterhuis; H van der Geld; T E Gfeltkamp
Journal:  J Neurol Sci       Date:  1967 May-Jun       Impact factor: 3.181

2.  Does myasthenic serum bind to the neuromuscular junction?

Authors:  D E McFarlin; W K Engel; A J Strauss
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

3.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

4.  Muscle lesions in myasthenia gravis.

Authors:  G M Fenichel
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

5.  Muscle lesions in myasthenia gravis. Discussion.

Authors:  W K Engel; D E McFarlin
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

6.  Mucin secretion and striated muscle in the human thymus.

Authors:  K Henry
Journal:  Lancet       Date:  1966-01-22       Impact factor: 79.321

7.  Myasthenia gravis.

Authors:  A J Strauss; P G Kemp; S D Douglas
Journal:  Lancet       Date:  1966-04-02       Impact factor: 79.321

8.  Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice.

Authors:  M J de Vries; W Hijmans
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397

9.  Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases.

Authors:  T E Feltkamp; A L van Rossum
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

10.  Thymitis and myasthenia gravis.

Authors:  G Goldstein
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321
View more
  8 in total

1.  Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis.

Authors:  R L Dawkins; A Eghtedari; E J Holborow
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

2.  The diagnosis of thymoma in myasthenia gravis.

Authors:  J A Aarli
Journal:  Ital J Neurol Sci       Date:  1983-12

Review 3.  Thymectomy in myasthenia gravis. A review.

Authors:  H J Oosterhuis
Journal:  Ital J Neurol Sci       Date:  1983-12

Review 4.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

5.  Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study.

Authors:  H Oosterhuis; J Bethlem
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

6.  Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis.

Authors:  J M Goust; A Castaigne; R Moulias
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

7.  Paraneoplastic syndromes in thymoma: an immunological perspective.

Authors:  Robert P Nelson; Robert M Pascuzzi
Journal:  Curr Treat Options Oncol       Date:  2009-02-06

8.  Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Authors:  Stéphane Mathis; Laurent Magy; Philippe Corcia; Karima Ghorab; Laurence Richard; Jonathan Ciron; Mathilde Duchesne; Jean-Michel Vallat
Journal:  Case Rep Neurol Med       Date:  2016-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.